CurrentRheuma
Get Weekly

Topic · page 38 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,481–1,520 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Rheumatology (Oxford)

    Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study

    Cohort study

  2. Clin Exp Rheumatol

    Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis

    Cross-sectional study

  3. Scand J Rheumatol

    Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis

    Research article

  4. Rheumatology (Oxford)

    Association between beverage consumption and risk of rheumatoid arthritis: a prospective study from the French E3N Cohort

    Cohort study

  5. Scand J Rheumatol

    The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development

    Cohort study

  6. Clin Exp Rheumatol

    Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities

    Case-control study

  7. Rheumatology (Oxford)

    A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis

    Mechanistic study

  8. Rheumatology (Oxford)

    Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids

    Secondary analysis

  9. Arthritis Care Res (Hoboken)

    Understanding COVID‐19 Risk in Patients With Immune‐Mediated Inflammatory Diseases: A Population‐Based Analysis of SARS–CoV‐2 Testing

    Cohort study

  10. Ann Rheum Dis

    Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

    Cohort study

  11. Arthritis Care Res (Hoboken)

    Vehicle Control as a Measure of Real‐World Driving Performance in Patients With Rheumatoid Arthritis

    Cohort study

  12. Ann Rheum Dis

    Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

    Secondary analysis

  13. Rheumatology (Oxford)

    Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis

    Meta-analysis

  14. Ann Rheum Dis

    Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study

    Cohort study

  15. Arthritis Care Res (Hoboken)

    Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population‐Based Cohort of Patients With Rheumatoid Arthritis

    Cohort study

  16. Ann Rheum Dis

    After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries

    Cohort study

  17. Joint Bone Spine

    Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019

    Cohort study

  18. Clin Exp Rheumatol

    Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy

    Cross-sectional study

  19. Arthritis Care Res (Hoboken)

    Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry

    Cohort study

  20. Clin Exp Rheumatol

    Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial

    Secondary analysis

  21. Rheumatology (Oxford)

    Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania

    Cross-sectional study

  22. Rheumatology (Oxford)

    Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study

    Secondary analysis

  23. Arthritis Care Res (Hoboken)

    Associations of Socioeconomic Status With Disease Progression in African Americans With Early Rheumatoid Arthritis

    Cohort study

  24. Rheumatology (Oxford)

    A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients

    Cross-sectional study

  25. Rheumatology (Oxford)

    Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis

    Cohort study

  26. Clin Exp Rheumatol

    Kihon Checklist validation in patients with rheumatoid arthritis: Italian translation, cross-cultural adaptation, and evaluation of the validity in comparison to two frailty screening tools based on the Fried phenotype and deficit accumulation model

    Diagnostic or prognostic study

  27. Clin Exp Rheumatol

    Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology

    Guideline or statement

  28. Rheumatology (Oxford)

    Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE

    Secondary analysis

  29. Rheumatology (Oxford)

    Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis

    Cohort study

  30. Arthritis Care Res (Hoboken)

    Reporting of Determinants of Health Inequities in Rheumatoid Arthritis Randomized Controlled Trials in Canada: A Scoping Review

    Research article

  31. Rheumatology (Oxford)

    Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world setting

    Cohort study

  32. J Rheumatol

    Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis

    Meta-analysis

  33. Clin Exp Rheumatol

    Correlation of serum citrullinated histone H3 levels with disease activity in patients with rheumatoid arthritis

    Cross-sectional study

  34. Rheumatology (Oxford)

    The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: a randomized controlled trial

    Randomized controlled trial

  35. Rheumatology (Oxford)

    Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis

    Cohort study

  36. Rheumatology (Oxford)

    Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis

    Cross-sectional study

  37. Rheumatology (Oxford)

    Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis

    Cohort study

  38. Clin Exp Rheumatol

    Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study

    Cross-sectional study

  39. Clin Exp Rheumatol

    High-throughput RNA-sequencing reveals novel targets of tofacitinib in the treatment of rheumatoid arthritis

    Mechanistic study

  40. Clin Exp Rheumatol

    Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients

    Cross-sectional study

All 1,564 Briefs in ExploreShowing Briefs 1,481–1,520 of 1,564, newest first